Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors
- PMID: 26487741
- PMCID: PMC5609485
- DOI: 10.1161/CIRCRESAHA.115.306629
Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors
Abstract
Rationale: Coronary artery disease (CAD) is a critical determinant of morbidity and mortality. Previous studies have identified several cardiovascular disease risk factors, which may partly arise from a shared genetic basis with CAD, and thus be useful for discovery of CAD genes.
Objective: We aimed to improve discovery of CAD genes and inform the pathogenic relationship between CAD and several cardiovascular disease risk factors using a shared polygenic signal-informed statistical framework.
Methods and results: Using genome-wide association studies summary statistics and shared polygenic pleiotropy-informed conditional and conjunctional false discovery rate methodology, we systematically investigated genetic overlap between CAD and 8 traits related to cardiovascular disease risk factors: low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, type 2 diabetes mellitus, C-reactive protein, body mass index, systolic blood pressure, and type 1 diabetes mellitus. We found significant enrichment of single-nucleotide polymorphisms associated with CAD as a function of their association with low-density lipoprotein, high-density lipoprotein, triglycerides, type 2 diabetes mellitus, C-reactive protein, body mass index, systolic blood pressure, and type 1 diabetes mellitus. Applying the conditional false discovery rate method to the enriched phenotypes, we identified 67 novel loci associated with CAD (overall conditional false discovery rate <0.01). Furthermore, we identified 53 loci with significant effects in both CAD and at least 1 of low-density lipoprotein, high-density lipoprotein, triglycerides, type 2 diabetes mellitus, C-reactive protein, systolic blood pressure, and type 1 diabetes mellitus.
Conclusions: The observed polygenic overlap between CAD and cardiometabolic risk factors indicates a pathogenic relation that warrants further investigation. The new gene loci identified implicate novel genetic mechanisms related to CAD.
Keywords: Women’s Genome Health Study; coronary artery disease; coronary heart disease; genetic pleiotropy; genome-wide association study; lipids; molecular epidemiology; myocardial infarction.
© 2015 American Heart Association, Inc.
Figures


Comment in
-
Coronary Artery Disease and Its Risk Factors: Leveraging Shared Genetics to Discover Novel Biology.Circ Res. 2016 Jan 8;118(1):14-6. doi: 10.1161/CIRCRESAHA.115.307937. Circ Res. 2016. PMID: 26837740 Free PMC article. No abstract available.
Similar articles
-
Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.Hypertension. 2014 Apr;63(4):819-26. doi: 10.1161/HYPERTENSIONAHA.113.02077. Epub 2014 Jan 6. Hypertension. 2014. PMID: 24396023 Free PMC article.
-
Shared genetic loci between depression and cardiometabolic traits.PLoS Genet. 2022 May 13;18(5):e1010161. doi: 10.1371/journal.pgen.1010161. eCollection 2022 May. PLoS Genet. 2022. PMID: 35560157 Free PMC article.
-
Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.Gene. 2020 Aug 5;750:144722. doi: 10.1016/j.gene.2020.144722. Epub 2020 Apr 30. Gene. 2020. PMID: 32360841
-
Multivariate analysis of genome-wide data to identify potential pleiotropic genes for type 2 diabetes, obesity and coronary artery disease using MetaCCA.Int J Cardiol. 2019 May 15;283:144-150. doi: 10.1016/j.ijcard.2018.10.102. Epub 2018 Oct 31. Int J Cardiol. 2019. PMID: 30459114 Review.
-
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. doi: 10.1517/14622416.2.1.S1. Pharmacogenomics. 2001. PMID: 11258203 Review.
Cited by
-
ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.J Virol. 2021 Jul 12;95(15):e0032721. doi: 10.1128/JVI.00327-21. Epub 2021 Jul 12. J Virol. 2021. PMID: 33963054 Free PMC article.
-
Genetic Risk in Coronary Artery Disease.Arq Bras Cardiol. 2018 Jul;111(1):62-63. doi: 10.5935/abc.20180130. Arq Bras Cardiol. 2018. PMID: 30110045 Free PMC article. No abstract available.
-
Powerful and efficient SNP-set association tests across multiple phenotypes using GWAS summary data.Bioinformatics. 2019 Apr 15;35(8):1366-1372. doi: 10.1093/bioinformatics/bty811. Bioinformatics. 2019. PMID: 30239606 Free PMC article.
-
Network Preservation Analysis Reveals Dysregulated Metabolic Pathways in Human Vascular Smooth Muscle Cell Phenotypic Switching.Circ Genom Precis Med. 2023 Aug;16(4):372-381. doi: 10.1161/CIRCGEN.122.003781. Epub 2023 Jun 30. Circ Genom Precis Med. 2023. PMID: 37387208 Free PMC article.
-
Molecular characterisation of ILRUN, a novel inhibitor of proinflammatory and antimicrobial cytokines.Heliyon. 2020 Jun 3;6(6):e04115. doi: 10.1016/j.heliyon.2020.e04115. eCollection 2020 Jun. Heliyon. 2020. PMID: 32518853 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous